MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-20-0059839
Atmus Pharma Private Limited
Atmus Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹16.5 Cr
▼ 10% YoY
Net profit · FY 2025
₹46.18 Lakh
Net margin 2.8%
EBITDA · FY 2025
₹1.24 Cr
EBITDA margin 7.5%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Atmus Pharma Private Limited
Data last updated:
Atmus Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 January 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2022PTC158653. Its GSTIN is 36AAWCA3633N1Z1 (Telangana).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Venkata Subrahmanyam Chittala and Machara Lakshmi Chittala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D.No. 15 – 31 – 1/Hig – V – 71/4F 404 4th Floor Niharika Enclave, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.5 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹46.18 Lakh (net margin 2.8%) and EBITDA of ₹1.24 Cr (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years.
Atmus Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-20-0059839).
Company details
CIN U24304TG2022PTC158653
Registration Number 158653
Incorporation Date 10 January 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-TS-20-0059839
Recognitions & Rankings of Atmus Pharma
Contact details
Atmus Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressD.No. 15 – 31 – 1/Hig – V – 71/4F 404 4th Floor Niharika Enclave, Phase V Kphb Colony Kukatpally Malkajgiri Telangana, Hyderabad, Telangana, India – 500085
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Atmus Pharma Private Limited, buy the company report.
Comprehensive company report
Atmus Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Atmus Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Atmus Pharma Private Limited, buy the company report.
Financials of Atmus Pharma Private Limited
FY 2025 filings availableAtmus Pharma Private Limited reported revenue of ₹16.5 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹16.5 Cr ▼ 10%
Net profit · FY 2025
₹46.18 Lakh margin 2.8%
EBITDA · FY 2025
₹1.24 Cr margin 7.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 90%
EBITDA CAGR growth
1 year
▲ 96%
3 years · compounded
▲ 218%
Revenue fell 10% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 90%. EBITDA rose 96% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.24 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹46.18 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 7.5% | |||
| Net Profit Margin | 2.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Atmus Pharma Private Limited, buy the company report.
Board of directors of Atmus Pharma Private Limited
Atmus Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Subrahmanyam Chittala | Director | 10 Jan 2022 | 4 Years 9 Months | Current |
| Machara Lakshmi Chittala | Director | 10 Jan 2022 | 4 Years 9 Months | Current |
Peer comparison
Atmus Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amarpali Cylinders Unit-Ii Private Limited | ₹16.62 Cr (FY 2025) | 1356.0% | Delhi, India | |||
| Ridra Export Private Limited | ₹16.54 Cr (FY 2025) | -25.0% | Kolkata, West Bengal, India | |||
| Shreeji Bottle Works Private Limited | ₹16.52 Cr (FY 2025) | -26.0% | Mumbai, Maharashtra, India | |||
| Esvee Pharma Chem Private Limited | ₹16.52 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India | |||
| Worksmart Technology Private Limited | ₹16.51 Cr (FY 2025) | 198.0% | Delhi, India | |||
| Atmus Pharma Private Limitedthis company | ₹16.5 Cr (FY 2025) | ₹46.18 Lakh | 2.8% | -10.0% | Hyderabad, Telangana, India | |
| Uttam Sons Private Limited | ₹16.49 Cr (FY 2025) | -4.0% | Delhi, India | |||
| Amitara Industries Private Limited | ₹16.45 Cr (FY 2025) | -48.0% | Mumbai, Maharashtra, India | |||
| Volga Bharath Agro Foods Private Limited | ₹16.44 Cr (FY 2025) | 8398.0% | Mukundapuram, Kerala, India | |||
| Gyan Agrico Industries Private Limited | ₹16.42 Cr (FY 2025) | 138.0% | Nawabganj, Uttar Pradesh, India | |||
| Scignohub India Private Limited | ₹16.39 Cr (FY 2024) | 61.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Atmus Pharma Private Limited, buy the company report.
Auditor
Atmus Pharma Private Limited is audited by A S NAIDU & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A S NAIDU & CO | FY 2023 | 008549S |
Shareholding
The shareholding of Atmus Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Atmus Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Atmus Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Atmus Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Atmus Pharma Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
Active EPFO establishments
1
GST
Atmus Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAWCA3633N1Z1 | Telangana | Active | 20 Jan 2022 |
To see the full GST registrations and return filing status of Atmus Pharma Private Limited, buy the company report.
Recent activity
Atmus Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Machara Lakshmi Chittala was appointed as Director on 10 Jan 2022.
AGM
Atmus Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Atmus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Machara Lakshmi Chittala was appointed as Director.
Appointed
Venkata Subrahmanyam Chittala was appointed as Director.
Incorporation
10 Jan 2022
Atmus Pharma Private Limited was registered on 10 Jan 2022 with Roc Hyderabad & aged 4 years 9 months as per MCA records.
Frequently asked questions
Atmus Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 January 2022 (4+ years old) and is registered under CIN U24304TG2022PTC158653.
Atmus Pharma has 2 current directors:
- Venkata Subrahmanyam Chittala - Director
- Machara Lakshmi Chittala - Director
The latest financial statements of Atmus Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Atmus Pharma is 36AAWCA3633N1Z1, registered in Telangana.
The CIN (Corporate Identification Number) of Atmus Pharma is U24304TG2022PTC158653. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atmus Pharma was incorporated on 10 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Atmus Pharma by revenue are Amarpali Cylinders Unit-Ii Private Limited, Ridra Export Private Limited, Shreeji Bottle Works Private Limited, Esvee Pharma Chem Private Limited, Worksmart Technology Private Limited and 5 more, all in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles).
Machara Lakshmi Chittala was appointed as Director on 10 Jan 2022. Venkata Subrahmanyam Chittala was appointed as Director on 10 Jan 2022.
Yes, Atmus Pharma is registered as an MSME under Udyam registration (number: UDYAM-TS-20-0059839).
The registered office of Atmus Pharma is at D.No. 15 – 31 – 1Hig – V – 714F 404 4th Floor Niharika Enclave, Phase V Kphb Colony Kukatpally Malkajgiri Telangana, Hyderabad, Telangana, India – 500085.
Atmus Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages